{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:48:54Z","timestamp":1786718934964,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijp.ijp_74_17","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T02:31:02Z","timestamp":1544754662000},"page":"227","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Vaccinium macrocarpon on MK-801-induced psychosis in mice"],"prefix":"10.4103","volume":"50","author":[{"given":"Disha","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RajeshA","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Balaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AshimKumar","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.247540-1","first-page":"453","volume-title":"Relapse and rehospitalization during maintenance treatment of schizophrenia.The effects of dose reduction and family treatment","author":"Schooler","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0253-7613.247540-2","first-page":"325","volume-title":"Catching up on schizophrenia: Natural history and neurobiology","author":"Lewis","year":"2000","journal-title":"Neuron"},{"key":"key-10.4103\/0253-7613.247540-3","first-page":"234","volume-title":"Schizophrenia: Positive and negative symptoms and syndromes","author":"Andreasen","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"key-10.4103\/0253-7613.247540-4","first-page":"S129","volume-title":"Schizophrenia: From developmental deviance to dopamine dysregulation","author":"Murray","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0253-7613.247540-5","first-page":"318","volume-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","author":"Coyle","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0253-7613.247540-6","first-page":"505","volume-title":"Binding of antipsychotic drugs to cortical 5-HT2A receptors: A PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients","author":"Trichard","year":"1998","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0253-7613.247540-7","first-page":"998","volume-title":"Glutamate receptor dysfunction and schizophrenia","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0253-7613.247540-8","first-page":"5844","volume-title":"Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon)","author":"Yan","year":"2002","journal-title":"J Agric Food Chem"},{"key":"key-10.4103\/0253-7613.247540-9","unstructured":"Organisation for Economic Co-operation and Development. Toxic Class Method. Guideline 423, adopted 23. 03.1996. Eleventh Addendum to the OECD Guidelines for the Testing of Chemicals Organisation. Paris: Economic Co-operation and Development; 2000. p. 15-49."},{"key":"key-10.4103\/0253-7613.247540-10","first-page":"49","volume-title":"Galantamine inhibits beta-amyloid aggregation and cytotoxicity","author":"Matharu","year":"2009","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0253-7613.247540-11","first-page":"1393","volume-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","author":"Andin\u00e9","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0253-7613.247540-12","first-page":"386","volume-title":"Clozapine improves deficient inhibitory auditory processing in DBA\/2 mice, via a nicotinic cholinergic mechanism","author":"Simosky","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/0253-7613.247540-13","first-page":"322","volume-title":"Do Escherichia coli extract and cranberry exert preventive effects on chronic bacterial prostatitis.Pilot study using an animal model?","author":"Kim","year":"2011","journal-title":"J Infect Chemother"},{"key":"key-10.4103\/0253-7613.247540-14","first-page":"759","volume-title":"Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice","author":"Chatterjee","year":"2012","journal-title":"Neurochem Res"},{"key":"key-10.4103\/0253-7613.247540-15","first-page":"310","volume-title":"Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia","author":"Chindo","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key-10.4103\/0253-7613.247540-16","doi-asserted-by":"crossref","unstructured":"Vogel HG, Vogel WH. Psychotropic and neurotropic activity. In: Vogel HG, Vogel WH. (eds) Drug Discovery and Evaluation. Springer: Berlin, Heidelberg;1997. P. 204-316.","DOI":"10.1007\/978-3-662-03333-3_5"},{"key":"key-10.4103\/0253-7613.247540-17","first-page":"46","volume-title":"Antipsychotic potentials of Ocimum sanctum leaves","author":"Kadian","year":"2015","journal-title":"Int J Pharm Sci Drug Res"},{"key":"key-10.4103\/0253-7613.247540-18","first-page":"183","volume-title":"Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): Potential role of inflammation activated myeloperoxidase","author":"Sajad","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0253-7613.247540-19","first-page":"88","volume-title":", Feather-Stone RM.A new and rapid colorimetric determination of acetylcholinesterase activity","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0253-7613.247540-20","first-page":"27","volume-title":"Methods for the detection of D-amino-acid oxidase","author":"Konno","year":"1998","journal-title":"Biol Proced Online"},{"key":"key-10.4103\/0253-7613.247540-21","first-page":"888","volume-title":"Analysis of glutamate, GABA, noradrenaline, dopamine, serotonin, and metabolites using microbore UHPLC with electrochemical detection","author":"Reinhoud","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"key-10.4103\/0253-7613.247540-22","first-page":"25","volume-title":"Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography.Differential effect of probenecid, haloperidol and yohimbine on the concentrations of biogenic amines and metabolites in various regions of rat brain","author":"Kim","year":"1987","journal-title":"J Chromatogr"},{"key":"key-10.4103\/0253-7613.247540-23","first-page":"953","volume-title":", Elsworth JD, Taylor JR, Youngren KD, Roth RH, et al. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine","author":"Jentsch","year":"1997","journal-title":"Science"},{"key":"key-10.4103\/0253-7613.247540-24","first-page":"1301","volume-title":"Recent advances in the phencyclidine model of schizophrenia","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0253-7613.247540-25","first-page":"309","volume-title":"Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2\/3 receptor agonists in mice","author":"Cook","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"key-10.4103\/0253-7613.247540-26","first-page":"626","volume-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","author":"Lipton","year":"1993","journal-title":"Nature"},{"key":"key-10.4103\/0253-7613.247540-27","first-page":"17","volume-title":"Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the D-serine levels in rat brain","author":"Hashimoto","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0253-7613.247540-28","first-page":"482","volume-title":"Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens","author":"Marcus","year":"2001","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0253-7613.247540-29","first-page":"1","volume-title":"BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia","author":"Geffen","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0253-7613.247540-30","first-page":"215","volume-title":"GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain","author":"Van","year":"1995","journal-title":"Brain Res"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:42Z","timestamp":1786714902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_74_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["247540"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_74_17","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}